Hing C. Wong, Ph.D. 13D/13G Filings for HCW Biologics Inc. (HCWB)

Hing C. Wong, Ph.D. 13D and 13G filings for HCW Biologics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-22
4:53 pm
Purchase		 2024-11-20 13D HCW Biologics Inc.
HCWB		 Hing C. Wong, Ph.D. 401,354
36.040%		 19,963increase
(+5.23%)		 Filing
2021-08-02
4:39 pm
Purchase		 2021-07-22 13D HCW Biologics Inc.
HCWB		 Hing C. Wong, Ph.D. 381,390
42.700%		 381,390increase
(New Position)		 Filing